Screener
Ligand Pharmaceuticals LGND Inventories
Inventories at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $1,006,702 | $174,927 |
| Short-term investments | 351,056 | 558,594 |
| Accounts receivable, net | 67,011 | 59,601 |
| Inventory | 10,263 | 9,126 |
| Short-term portion of financial royalty assets, net | 12,982 | 22,792 |
| Income taxes receivable | 2,911 | 1,446 |
| Other current assets | 6,191 | 5,785 |
| Total current assets | 1,457,116 | 832,271 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's inventories?
- Ligand Pharmaceuticals (LGND) reported inventories of $10.26M in Q2 2026.
- How has Ligand Pharmaceuticals's inventories changed year-over-year?
- Ligand Pharmaceuticals's inventories decreased by 33.7% year-over-year, from $15.49M to $10.26M.
- What is the long-term trend for Ligand Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's inventories has grown at a -19.2% compound annual growth rate (CAGR), from $26.49M to $9.13M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Ligand Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude